These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21816765)

  • 1. Effect of applying the new CLSI imipenem susceptibility breakpoints for Enterobacteriaceae in Hong Kong.
    Ho PL; Lai EL; Chow KH; Cheng VC
    J Antimicrob Chemother; 2011 Nov; 66(11):2671-3. PubMed ID: 21816765
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of resistance phenotypes to beta-lactam antibiotics among 4800 isolates of Enterobacteriaceae and distribution of beta-lactamases.
    Ben Redjeb S; Fournier G; Philippon A; Ben Yaghlane H; Labia R; Boujnah A
    J Chemother; 1989 Jul; 1(4 Suppl):336-8. PubMed ID: 16312428
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbapenemases in enterobacteria, Hong Kong, China, 2009.
    Chu YW; Tung VW; Cheung TK; Chu MY; Cheng N; Lai C; Tsang DN; Lo JY
    Emerg Infect Dis; 2011 Jan; 17(1):130-2. PubMed ID: 21192875
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
    Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Imipenem-Susceptible but Meropenem-Resistant
    Kanazawa S; Sato T; Kohira N; Ito-Horiyama T; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438934
    [No Abstract]   [Full Text] [Related]  

  • 7. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
    Deshpande LM; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):367-72. PubMed ID: 17020798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).
    Basu S; Singh AK; Nair GB
    Natl Med J India; 2010; 23(5):261-2. PubMed ID: 21250578
    [No Abstract]   [Full Text] [Related]  

  • 11. Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints.
    Landman D; Salamera J; Singh M; Quale J
    J Clin Microbiol; 2011 Nov; 49(11):3931-3. PubMed ID: 21880962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
    Goossens H; Grabein B
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producers.
    Samuel JR; Natarajan M; Rizkalla E; Livermore DM; Warner M; Jenkinson P
    J Antimicrob Chemother; 2005 Nov; 56(5):984-5. PubMed ID: 16188914
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done.
    Murray PR
    MLO Med Lab Obs; 2013 May; 45(5):26, 28, 30. PubMed ID: 23763046
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.
    Anderson KF; Lonsway DR; Rasheed JK; Biddle J; Jensen B; McDougal LK; Carey RB; Thompson A; Stocker S; Limbago B; Patel JB
    J Clin Microbiol; 2007 Aug; 45(8):2723-5. PubMed ID: 17581941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New quality control strain for use in routine testing for production of extended-spectrum Beta-lactamases by enterobacteriaceae.
    Mortensen JE; Bernier M; Gray LD; Dolan S; Hanson ND; Moland ES; Abdalhamid B
    J Clin Microbiol; 2005 May; 43(5):2545. PubMed ID: 15872308
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial susceptibility and extended-spectrum beta-lactamases of Hong Kong isolates of enterobacteriaceae.
    Lyon DJ; Scheel O; Adeyemi-Doro FA; Ling TK; Cheng AF; Norrby SR
    Scand J Infect Dis Suppl; 1996; 101():17-20. PubMed ID: 9060047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea.
    Kim J; Lim YM; Jeong YS; Seol SY
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1572-5. PubMed ID: 15793142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
    Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC
    J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.